Alzheimers disease/Down syndrome therapeutic (Prothena)

N/A

Report date: 2025/03/20 09:36:54
NME

Base Information

Drug NameAlzheimers disease/Down syndrome therapeutic (Prothena)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsDown SyndromeAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProthena Corp Plc
China Registration ClassN/A

Develop Information

Active CompaniesProthena Corp Plc
Inactive CompaniesN/A
Active IndicationsDown SyndromeAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A